UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

UPDATE: JPMorgan Starts IDEXX Laboratories (IDXX) at Overweight

January 29, 2021 4:42 AM EST

(Updated - January 29, 2021 5:21 AM EST)

JPMorgan analyst Chris Schott initiates coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Overweight rating and a price target of $570.00.

The analyst comments "We view Idexx as the undisputed leader in the space (~55-60% market share) and... More